Lifeboat Foundation

(NewsNation) — A scientific expedition off the coast of Alaska sparked speculation among livestream viewers when cameras on a remote-controlled dive vehicle captured a mysterious object at the bottom of the ocean.

The National Oceanic and Atmospheric Administration conducted the Aug. 30 expedition and described the object as a “golden orb” that “struck an imaginative chord.”

So, what was it?

The AI revolution is here — and one pioneer of the technology says it will be accessible to all in the upcoming years.

Mustafa Suleyman, the co-founder of DeepMind, Google’s AI division, told CNBC during an interview that everybody is going to have their own AI-powered personal assistants within the next five years as the technology becomes cheaper and more widespread.

In particular, Suleyman, now the CEO of Inflection AI, the tech startup behind an AI chatbot called Pi, said that everybody will have access to an AI that “knows you,” is “super smart,” and “understands your personal history.”

A study has linked the development in kids of any of food allergy, asthma, eczema and rhinitis to a common factor – an unbalanced gut microbiome.

Researchers have long been intrigued by the gut microbiome in the development of allergic diseases. But this Canadian study is unique in identifying a common origin in infancy across the four separate allergic diseases. As well, it explored the composition of gut bacteria in children before and following allergic sensitization.

As each allergic disease has a separate list of symptoms, they are usually studied on their own. “But when you look at what is going wrong at a cellular level, they actually have a lot in common,” notes Dr. Charisse Petersen, co-senior author and a researcher at BC Children’s Hospital Research Institute and BC Children’s Hospital.

Many people think of generative AI as a tool that allows them to use their own words to ask questions or generate copy and images—both of which it does remarkably well. However, it also has incredible potential to transform our personal and professional work—helping us access, consume, and utilize the untapped information that floods our inboxes and languishes in archives.

Adobe recently conducted research on digital workers’ perceptions of AI technologies, as well as their value in the workplace. We surveyed 6,049 digital workers across five countries—the U.S., UK, Australia, India, and Japan—including both rank-and-file employees and senior leaders who are using digital technologies (including digital documents) in their workplaces. The findings reveal their perceptions and aspirations around how AI can change the way we work. Following are the top three insights from the research:

Facing large payouts from wildfire lawsuits, electric companies are passing their added costs on to ratepayers.

Google Deepmind will soon begin researching autonomous language agents such as Auto-GPT, potentially boosting the viable applications of LLMs such as Gemini.

Google DeepMind is looking for researchers and engineers to help build increasingly autonomous language agents, Edward Grefenstette, director of research at Google DeepMind, announced at X.

Such AI agents already exist in early stages, with Auto-GPT being one of the earliest examples. The basic idea is to create a system that autonomously achieves a given goal using a mix of prompt engineering, self-prompting, memory, and other system parts. While such agents are already showing promising results, they are still far from being able to achieve good results on their own and usually require human feedback and decision-making.

Today’s retailers are faced with a clear opportunity for transformation. Consumer expectations are constantly evolving, challenging retailers to keep pace. A blend of online and in-person shopping forged during the pandemic persists, forcing retailers to deliver a highly personalized omnichannel experience. And retailers’ values are becoming as important to consumers as their products and services.

Researchers reported the discovery of a new antibiotic, clovibactin.

The right product can reduce staff and clinician burnout, but it needs to include a human element.